M&A Deal Summary |
|
|---|---|
| Date | 2025-08-12 |
| Target | LayerBio |
| Sector | Life Science |
| Buyer(s) | PainReform |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 2007 |
| Sector | Life Science |
| Employees | 2 |
| Revenue | 10M USD (2023) |
PainReform is a specialty pharmaceutical company that engages in the development of products for the treatment of pain in Israel. The company develops PRF-110, a product based on local anesthetic ropivacaine, which completed Phase II clinical study in hernia repair. PainReform was founded in 2007 and is based in Tel Aviv, Israel.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 1 of 1 |
| State: Massachusetts M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2025 M&A | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2025-02-18 |
DeepSolar
Ramat Gan, Israel DeepSolar is an AI-powered analytics company that optimizes the efficiency and profitability of solar energy assets. DeepSolar leverages proprietary software and AI-driven automation tools, providing a significant competitive advantage in solar energy management. |
Buy | - |